University Hospitals Offers the Following Cell Therapy Clinical Trials

May 2018

 

CASE2Z16: Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
P.I.: Folashade Otegbeye, MD
Clinicaltrials.gov #NCT02890758

CASE2417: AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
P.I.: Paolo Caimi, MD
Clinicaltrials.gov #NCT03434769

CASE 1Z14: Intra-Osseous Co-Transplant of Cord Blood and Mesenchymal Stomal Cells: A Feasibility Study
P.I.: Leland Metheny, MD
Clinicaltrials.gov #NCT02181478

CASE 6307: O6-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients with MGMT Positive Tumors with Infusion of Autologous P140KMGMT+Hematopoietic Progenitors to Protect Hematopoiesis
P.I.: Stan Gerson, MD
Clinicaltrials.gov #NCT01269424

CASE 3113: Pilot Trial of a Type I-Polarized Autologous Dendritic Cell Vaccine Incorporating Tumor Blood Vessel Antigen-Derived Peptides in Patients with Metastatic Breast Cancer
P.I.: Joseph Baar, MD
Clinicaltrials.gov #NCT02479230

BMT CTN 1401: Personalized DC vaccine for multiple myeloma
P.I.: Ehsan Malek, MD
ClinicalTrials.gov Identifier: NCT02728102

For more information about clinical trials taking place at UH Seidman Cancer Center contact Marcos de Lima, MD amarcos.delima@uhhospitals.org.

Share
Facebook
Twitter
Pinterest
Email
Print